AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 115 filers reported holding AMAG PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $5,114,000 | -5.7% | 218,534 | +23.0% | 0.01% | 0.0% |
| Q4 2015 | $5,421,000 | -39.6% | 177,742 | -21.4% | 0.01% | -47.1% |
| Q3 2015 | $8,979,000 | -37.1% | 226,015 | +9.3% | 0.02% | -26.1% |
| Q2 2015 | $14,276,000 | +407.1% | 206,731 | +301.4% | 0.02% | +360.0% |
| Q1 2015 | $2,815,000 | +10.6% | 51,503 | -13.0% | 0.01% | +25.0% |
| Q4 2014 | $2,546,000 | +24.8% | 59,176 | -7.4% | 0.00% | 0.0% |
| Q3 2014 | $2,040,000 | +44.7% | 63,923 | +4.4% | 0.00% | +33.3% |
| Q4 2013 | $1,410,000 | +34.9% | 61,221 | +25.8% | 0.00% | +50.0% |
| Q3 2013 | $1,045,000 | -9.8% | 48,655 | -6.6% | 0.00% | 0.0% |
| Q2 2013 | $1,159,000 | – | 52,076 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 740,585 | $17,330,000 | 8.11% |
| Palo Alto Investors LP | 2,906,194 | $68,005,000 | 5.28% |
| Opaleye Management Inc. | 220,000 | $5,148,000 | 3.21% |
| Endurant Capital Management LP | 265,180 | $6,205,000 | 2.01% |
| FALCON POINT CAPITAL, LLC | 381,081 | $8,917,000 | 1.54% |
| STELLIAM INVESTMENT MANAGEMENT, LP | 1,470,000 | $34,398,000 | 1.06% |
| AlphaOne Investment Services, LLC | 91,824 | $2,149,000 | 0.88% |
| ASHFORD CAPITAL MANAGEMENT INC | 153,325 | $3,588,000 | 0.85% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 55,097 | $1,289,000 | 0.84% |
| Camber Capital Management LP | 600,000 | $14,040,000 | 0.82% |